Track topics on Twitter Track topics that are important to you
In this exclusive interview, Fintan Walton talks to Alison Coutts, Executive Director at eG Capital in Sydney, Australia. Alison reviews some of the major changes she has observed in the biotech and pharmaceutical industry in Australia over the last 12 months, reflecting on the progress that many companies have made and the general maturation of the industry as a whole. She discusses the increasing interest which Australia’s biotech sector is receiving from international pharmaceutical companies and comments on the nature of the relationship which these major players are intent on seeking. Alison also provides a look ahead to 2008 and what it might hold for Australia’s many biotech companies.
Original Article: eG Capital: Australian Biotech: A 2007 Perspective from Alison CouttsNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...